[go: up one dir, main page]

GB201610502D0 - Dosage regimen - Google Patents

Dosage regimen

Info

Publication number
GB201610502D0
GB201610502D0 GBGB1610502.5A GB201610502A GB201610502D0 GB 201610502 D0 GB201610502 D0 GB 201610502D0 GB 201610502 A GB201610502 A GB 201610502A GB 201610502 D0 GB201610502 D0 GB 201610502D0
Authority
GB
United Kingdom
Prior art keywords
dosage regimen
regimen
dosage
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1610502.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Intellectual Property Development Ltd
Original Assignee
GlaxoSmithKline Intellectual Property Development Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GlaxoSmithKline Intellectual Property Development Ltd filed Critical GlaxoSmithKline Intellectual Property Development Ltd
Priority to GBGB1610502.5A priority Critical patent/GB201610502D0/en
Publication of GB201610502D0 publication Critical patent/GB201610502D0/en
Priority to PCT/EP2017/064682 priority patent/WO2017216297A1/en
Ceased legal-status Critical Current

Links

GBGB1610502.5A 2016-06-16 2016-06-16 Dosage regimen Ceased GB201610502D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1610502.5A GB201610502D0 (en) 2016-06-16 2016-06-16 Dosage regimen
PCT/EP2017/064682 WO2017216297A1 (en) 2016-06-16 2017-06-15 Dosage regimen

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1610502.5A GB201610502D0 (en) 2016-06-16 2016-06-16 Dosage regimen

Publications (1)

Publication Number Publication Date
GB201610502D0 true GB201610502D0 (en) 2016-08-03

Family

ID=56895078

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1610502.5A Ceased GB201610502D0 (en) 2016-06-16 2016-06-16 Dosage regimen

Country Status (1)

Country Link
GB (1) GB201610502D0 (en)

Similar Documents

Publication Publication Date Title
GB201713653D0 (en) Dosage regimen
IL254818A0 (en) Ribociclib tablet
PL3484451T3 (en) Dosage form
IL247083B (en) Fgh-18 dosage regimen
GB201521217D0 (en) Dosage regimens
GB201418710D0 (en) Dosage regimen
ZA201800217B (en) Novel dosage regimen tiacumicin compound
GB201607548D0 (en) Solid dosage form
IL266255A (en) Novel dosage regimen
GB201516836D0 (en) Dosing regimen of combination
GB201511252D0 (en) Tablet
IL248782B (en) Treatment regimen tiacumicin compound
GB201617850D0 (en) Dosage regimen
GB201610502D0 (en) Dosage regimen
GB201521216D0 (en) Dosage regimen
HK40012526A (en) Novel dosage regimen
GB201720519D0 (en) Dosing regimen
GB201713224D0 (en) Regimen
GB201718106D0 (en) Dosing regimen
GB201718000D0 (en) Dosing regimen
GB201717694D0 (en) Dosing regimen
GB201614232D0 (en) Regimen
GB201418708D0 (en) Dosage regimen
GB201609758D0 (en) Dosing Regimen
GB201400171D0 (en) Dosage regimen

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)